The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Davidson, Michael H.
Item TypeName
Concept Atherosclerosis
Academic Article Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
Academic Article What kinds of data should be available to probe the effects of nutrients, food supplements or vitamins on serum lipoprotein levels and/or atherosclerosis?
Academic Article Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents.
Academic Article The safety and immunogenicity of a CETP vaccine in healthy adults.
Academic Article Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors.
Academic Article Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives.
Academic Article ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.
Academic Article Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.
Academic Article Effect of ACAT inhibition on the progression of coronary atherosclerosis.
Academic Article Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects.
Academic Article Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk.
Academic Article Medical and cost burden of atherosclerosis among patients treated in routine clinical practice.
Academic Article Usefulness of increased skin cholesterol to identify individuals at increased cardiovascular risk (from the Predictor of Advanced Subclinical Atherosclerosis study).
Academic Article Atherosclerosis surrogate imaging trials come of age: for better or for worse?
Academic Article Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
Academic Article Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Academic Article Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
Academic Article Apolipoprotein measurements: is more widespread use clinically indicated?
Academic Article The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk.
Academic Article Rosuvastatin in elderly patients.
Academic Article Is it over for ezetimibe?
Academic Article Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
Academic Article Effects of dietary supplementation with marine lipid concentrate on the plasma lipoprotein composition of hypercholesterolemic patients.
Academic Article Update on CETP inhibition.
Academic Article Therapies targeting exogenous cholesterol uptake: new insights and controversies.
Academic Article Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women.
Academic Article The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
Academic Article Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis.
Academic Article Pharmacological approaches to modifying HDL: more basic science to understand HDL metabolism is necessary. Editorial to: "NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells" by Xin Ma et al.
Academic Article Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
Academic Article Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
Academic Article ETC-1002: a future option for lipid disorders?
Academic Article Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Academic Article [Official document of the International Society of Atherosclerosis: general recommendations for treatment of dyslipidemia. Executive summary].
Academic Article Carotid adventitial vasa vasorum and intima-media thickness in a primary prevention population.
Academic Article Therapeutic ultrasound: Increased HDL-Cholesterol following infusions of acoustic microspheres and apolipoprotein A-I plasmids.
Academic Article Changing characteristics of statin-related cIMT trials from 1988 to 2006.
Academic Article Can We Cure Atherosclerosis?
Academic Article Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
Academic Article Triglyceride-rich lipoprotein cholesterol (TRL-C): the ugly stepsister of LDL-C.
Academic Article Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
Academic Article Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Academic Article Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis.
Academic Article How I treat statin-associated side effects in an outpatient setting.
Academic Article Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
Search Criteria
  • Atherosclerosis